Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK to improve blood glucose control in adults with type 2 diabetes mellitus
While semaglutide demonstrated a favorable safety and tolerability profile and was associated with modest changes in AD-related biomarkers, including plasma high-sensitivity C-reactive protein and AD-relevant cerebrospinal fluid biomarkers, it did not demonstrate superiority over placebo on the primary clinical endpoint, change in the clinical dementia ratingsum of boxes (CDR-SB) score at week 104 68
doi: 10.1136/jcp.2009.072561 114 KomaroffAL
Bake it during your weekend meal prep and youll have effortless, high-quality protein breakfasts all week long
A total of 392 adult and pediatric subjects 12 years of age and older with CSU were evaluated for safety in three randomized, double-blind, parallel-group, multicenter, placebo-controlled, studies, Study A, B, and C, conducted under a master protocol (CUPID) for 36 weeks [see Clinical Studies (14.7)]
They're doing it in vials, which makes it a little bit different
